Polyneuropathies (Polyneuropathy)
2766
relevant articles (142 outcomes,
246 trials/studies)
found for this Disease
Description:
Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.
Also Known As:
Polyneuropathy; Polyneuropathy, Critical Illness; Polyneuropathy, Familial; Polyneuropathy, Inherited; Polyneuropathy, Motor; Acquired Polyneuropathies; Acquired Polyneuropathy; Critical Illness Polyneuropathies; Critical Illness Polyneuropathy; Familial Polyneuropathies; Familial Polyneuropathy; Inherited Polyneuropathies; Inherited Polyneuropathy; Motor Polyneuropathies; Motor Polyneuropathy; Polyneuropathies, Acquired; Polyneuropathies, Critical Illness; Polyneuropathies, Familial; Polyneuropathies, Inherited; Polyneuropathies, Motor; Polyneuropathy, Acquired
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
| 1. | Ando, Y:
12 articles
(11/2007 - 02/2000)
|
| 2. | Ando, Yukio:
12 articles
(06/2007 - 09/2002)
|
| 3. | Suhr, Ole B:
9 articles
(12/2005 - 03/2002)
|
| 4. | Suhr, O B:
8 articles
(11/2007 - 01/2000)
|
| 5. | Nakamura, Masaaki:
7 articles
(07/2006 - 09/2002)
|
| 6. | Ericzon, Bo-Göran:
6 articles
(11/2007 - 08/2003)
|
| 7. | Terazaki, H:
6 articles
(04/2004 - 02/2000)
|
| 8. | Saraiva, M J:
5 articles
(10/2007 - 04/2000)
|
| 9. | Notermans, N C:
5 articles
(07/2007 - 10/2000)
|
| 10. | Nakamura, M:
5 articles
(04/2004 - 02/2000)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Polyneuropathies:
| 1. | Intravenous Immunoglobulins (IVIG)FDA Link
|
| 2. | Immunoglobulins (Immunoglobulin)IBA
|
| 3. | Adrenal Cortex Hormones (Corticosteroids)IBA
|
| 4. | Immunoglobulin M (IgM)IBA
|
| 5. | Prednisone (Sone)FDA LinkGeneric
|
| 6. | Immunoglobulin G (IgG)IBA
05/01/2002
- " CONCLUSIONS: Intravenous immunoglobulin therapy was beneficial in 8 (40%) of our 20 patients with polyneuropathy and IgG monoclonal gammopathy of undetermined significance. " 12/01/2003
- " I propose that a) there is a higher incidence of Chronic Immune Dysschwannian/Dysneuronal Polyneuropathy-like neuropathy in type-2 diabetes patients and in patients with a strong family history of type-2 diabetes, and b) the intravenous immunoglobulin-G-treatable neuropathy in type-2 diabetes can be brought on by the genetico-diabetoid-2 state. " 12/01/2003
- " The intravenous immunoglobulin-G responsive type-2 diabetes polyneuropathy usually is dysschwannian, sometimes mainly dysneuronal intravenous immunoglobulin-G, the most beneficial and safest treatment, is costly, but if intravenous immunoglobulin-G-treatability of a dysimmune component of type-2 diabetes neuropathy is overlooked, dismissed or rejected, as commonly happens, other costs are high regarding the patient's worsening morbidity and disability, and resultant need for increased medical care. " 07/01/2003
- " The case of a 65-year-old woman with polyneuropathy, organomegaly, skin changes and monoclonal gammopathy of IgG-lambda type is described. " 10/22/1997
- " This report describes the first patient with acute demyelinating polyneuropathy with prominent sensory symptoms who had a high titer of serum IgG anti-GD1b antibody. "
Order ALL the reference details at left...
|
| 7. | rituximab (Mabthera)FDA Link
|
| 8. | SteroidsIBA
|
| 9. | Lidocaine (Xylocaine)FDA LinkGeneric
|
| 10. | Thalidomide (Thalomid)FDA Link
|
|
Therapies and Procedures
| 1. | Plasmapheresis
|
| 2. | Drug Therapy (Chemotherapy)
|
| 3. | Liver Transplantation
|
| 4. | Transplants (Transplant)
|
| 5. | Transplantation (Transplant Recipients)
06/01/1996
- " One year after transplantation, her general condition has markedly improved, but there is still a disabling polyneuropathy. " 10/27/2001
- " By contrast, for these times after transplantation, a composite score of nerve conduction abnormalities, an independent measure of severity of polyneuropathy, was not significantly worse and, in fact, was significantly improved. " 09/01/1992
- " After transplantation, muscle strength reverted to normal in all patients, polyneuropathy improved and in all but 2 patients recovery of neuropsychological functioning was observed. " 01/01/2008
- " All patients with Familial Amyloidotic Polyneuropathy should be followed after transplantation to assess for a deterioration in cardiac function." 02/01/2007
- " Domino transplantation using livers from patients with familial amyloidotic polyneuropathy: should we halt?"
Order ALL the reference details at left...
|
|